Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy.Published in:Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 3, p. 363, doi. 10.1007/s00432-009-0662-9By:Jung, Tatjana I.;Hoffmann, Falk;Glaeske, Gerd;Felsenberg, DieterPublication type:Article
Pattern of intravenous bisphosphonate use in outpatient care in Germany.Published in:Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 9, p. 896, doi. 10.1002/pds.1634By:Hoffmann, Falk;Jung, Tatjana I.;Felsenberg, Dieter;Glaeske, GerdPublication type:Article